Lowest Value Trap Drug Manufacturers - Specialty & Generic Stocks 2026
Safest value Drug Manufacturers - Specialty & Generic stocks in 2026 with the lowest Value Trap scores. Avoid value traps with CirclFi's institutional-grade multi-signal screening.
Which Drug Manufacturers - Specialty & Generic Stocks Rank Highest by Trap Score?
60 qualifying of 110 drug manufacturers - specialty & generic equities covered.
| # | Ticker | Company | Signal | QOC | Price | Trap Score |
|---|---|---|---|---|---|---|
| 1 | RDY | Dr. Reddy's Laboratories Limited | 8.8 | $12.16 | 6/100 | |
| 2 | ZTS | Zoetis Inc. | 9.3 | $75.02 | 6/100 | |
| 3 | BCRX | BioCryst Pharmaceuticals, Inc. | 8.4 | $9.87 | 6/100 | |
| 4 | AMPH | Amphastar Pharmaceuticals, Inc. | 9.4 | $21.88 | 8/100 | |
| 5 | UTHR | United Therapeutics Corporation | 9.6 | $527.91 | 8/100 | |
| 6 | ALKS | Alkermes plc | 8.6 | $48.90 | 12/100 | |
| 7 | AMRX | Amneal Pharmaceuticals, Inc. | 8.3 | $18.01 | 12/100 | |
| 8 | CRON | Cronos Group Inc. | 7.4 | $3.39 | 12/100 | |
| 9 | BHC | Bausch Health Companies Inc. | 6.8 | $6.30 | 13/100 | |
| 10 | HROW | Harrow, Inc. | 7.0 | $38.54 | 13/100 | |
| 11 | P••• | Phibro ••••• | •.• | $•••.•• | ••.•% | |
| 12 | I••• | Ironwood ••••• | •.• | $•••.•• | ••.•% | |
| 13 | T••• | Takeda ••••• | •.• | $•••.•• | ••.•% | |
| 14 | A••• | ANI ••••• | •.• | $•••.•• | ••.•% | |
| 15 | E••• | Eton ••••• | •.• | $•••.•• | ••.•% | |
| 16 | L••• | Lantheus ••••• | •.• | $•••.•• | ••.•% | |
| 17 | O••• | Organogenesis ••••• | •.• | $•••.•• | ••.•% | |
| 18 | S••• | Supernus ••••• | •.• | $•••.•• | ••.•% | |
| 19 | P••• | Prestige ••••• | •.• | $•••.•• | ••.•% | |
| 20 | B••• | BioAge ••••• | •.• | $•••.•• | ••.•% |
You’re seeing 10 of 60 qualifying stocks.
Access the complete dataset with 13 institutional-grade models.
How CirclFi Ranks Drug Manufacturers - Specialty & Generic Stocks
CirclFi publishes a valuation page for all 5,877 US equities it covers and can state a 13-model median fair value for the 3,801 with enough filing history for at least two models to run, 52 of them in Drug Manufacturers - Specialty & Generic — reading SEC EDGAR filings, FRED macro data, and GDELT sentiment.
For Drug Manufacturers - Specialty & Generic stocks, CirclFi adjusts sector-relative benchmarks — comparing margins, capital intensity, and growth rates against Drug Manufacturers - Specialty & Generic industry medians.
Profitability Matrix
ROIC, Gross Margin expansion, and FCF Yield analysis.
Growth Vector
Revenue compounding vs. sector benchmarks.
Stability Index
Altman Z-Score, debt resilience, and earnings variance.
What Should You Know About This Drug Manufacturers - Specialty & Generic Screen?
What are the lowest value trap drug manufacturers - specialty & generic stocks in 2026?
CirclFi identifies the lowest value trap drug manufacturers - specialty & generic stocks 2026 using 13 institutional-grade valuation models including Bayesian DCF (10,000 Monte Carlo simulations), EPV (Greenwald framework), and EROIC Spread (McKinsey). Rankings update daily from SEC EDGAR filings. The current top-ranked stock is RDY (Dr. Reddy's Laboratories Limited).
How does CirclFi rank Drug Manufacturers - Specialty & Generic stocks?
Stocks are ranked by Trap Score derived from CirclFi's proprietary models. Each model independently processes SEC EDGAR financial data (700+ XBRL tags), FRED macroeconomic indicators, and GDELT news sentiment to produce confidence-weighted fair value estimates. The ranking methodology combines multiple valuation approaches — intrinsic, relative, scenario, and ensemble — for maximum robustness.
How often is the lowest value trap drug manufacturers - specialty & generic stocks 2026 list updated?
This list is recalculated daily after US market close. Every stock is re-valued through all 13 models using the latest SEC EDGAR filings, market prices, and FRED macroeconomic data. Rankings can change daily as new financial data becomes available or market prices shift relative to fair value estimates.
What is the Quality of Company (QOC) score?
The QOC score is a 0-10 composite rating derived from 32 fundamental signals across four pillars: profitability (ROE, ROIC, margins), growth (revenue CAGR, earnings acceleration), stability (earnings volatility, debt coverage), and capital efficiency (asset turnover, free cash flow yield). Higher scores indicate stronger fundamentals. Scores above 7 represent top-tier companies.
How does this list compare to other stock screeners?
Unlike simple screeners that filter by P/E or dividend yield, CirclFi runs 13 independent institutional-grade valuation models on every stock — including Bayesian DCF with Monte Carlo simulation, Greenwald EPV, and McKinsey economic profit frameworks. Each company is scored on 32 fundamental signals drawn from 700+ SEC EDGAR XBRL tags, then re-valued after every US market close. Most retail screeners use one or two metrics; this screen ranks 110 Drug Manufacturers - Specialty & Generic companies on the median of all 13.
Buy with Gumroad